Related Experiment Video
Updated: Jul 20, 2025

A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings
Published on: November 9, 2016
Effectiveness of a Novel Tablet Application in Reducing Guideline Deviations During Pediatric Cardiac Arrest: A
Francesco Corazza1, Marta Arpone2, Giacomo Tardini2
1Pediatric Emergency Division, Department of Women's and Children's Health, University Hospital of Padova, Padova, Italy.
Insights
The PediAppRREST app significantly reduced guideline deviations during simulated pediatric cardiac arrest, improving team performance. This tool enhances resuscitation efforts for critically ill children.
Area of Science:
- Pediatric Emergency Medicine
- Clinical Resuscitation Science
- Health Informatics
Background:
- Deviations from international resuscitation guidelines are common in pediatric cardiac arrest management.
- These deviations negatively impact clinical outcomes for critically ill children.
- A novel interactive tablet application, PediAppRREST, was developed to address this issue.
Purpose of the Study:
- To evaluate the effectiveness of the PediAppRREST application in improving pediatric cardiac arrest management.
- To assess the app's impact on adherence to resuscitation guidelines in simulated in-hospital settings.
Main Methods:
- A multicenter, 3-group, simulation-based randomized clinical trial involving 100 teams.
- Participants included residents in pediatrics, emergency medicine, and anesthesiology.
- Interventions: PediAppRREST app, paper-based Pediatric Advanced Life Support (PALS) card, or no cognitive aid.
Main Results:
- The PediAppRREST group showed significantly fewer deviations from resuscitation guidelines compared to both control groups (P < .001).
- Clinical Performance Tool scores were significantly higher in the PediAppRREST group versus controls (P = .002 vs. PALS; P = .01 vs. no aid).
- No significant differences were observed in chest compression quality or perceived workload.
Conclusions:
- The PediAppRREST application effectively reduces guideline deviations during simulated pediatric cardiac arrest.
- Utilizing PediAppRREST leads to improved overall team clinical performance in resuscitation scenarios.
- This technology holds promise for enhancing the quality of care during pediatric emergencies.
Importance:
Deviations from international resuscitation guidelines during the management of pediatric cardiac arrest are frequent and affect clinical outcomes. An interactive tablet application (app), PediAppRREST, was developed to reduce guideline deviations during pediatric cardiac arrest.
Objective:
To assess the effectiveness of PediAppRREST in improving the management of simulated in-hospital pediatric cardiac arrest.
Design, Setting, And Participants:
This multicenter 3-group simulation-based randomized clinical trial was conducted from September 2020 to December 2021 at 4 Italian university hospitals (Padua, Florence, Rome, Novara). Participants included residents in pediatrics, emergency medicine, and anesthesiology. Analyses were conducted as intention-to-treat. Data were analyzed from January to June 2022.
Interventions:
Teams were randomized to 1 of 3 study groups: an intervention group that used the PediAppRREST app; a control group that used a paper-based cognitive aid, the Pediatric Advanced Life Support (PALS) pocket card; and a control group that used no cognitive aids. All the teams managed the same standardized simulated scenario of nonshockable pediatric cardiac arrest.
Main Outcomes And Measures:
The primary outcome was the number of deviations from guidelines, measured by a 15-item checklist based on guideline recommendations. The main secondary outcomes were quality of chest compressions, team clinical performance (measured by the Clinical Performance Tool), and perceived team leader's workload. Study outcomes were assessed via video reviews of the scenarios.
Results:
Overall 100 teams of 300 participants (mean [SD] age, 29.0 [2.2] years; 195 [65%] female) were analyzed by intention-to-treat, including 32 teams randomized to the PediAppRREST group, 35 teams randomized to the PALS control group, and 33 teams randomized to the null control group. Participant characteristics (210 pediatric residents [70%]; 48 anesthesiology residents [16%]; 42 emergency medicine residents [14%]) were not statistically different among the study groups. The number of deviations from guidelines was significantly lower in the PediAppRREST group than in the control groups (mean difference vs PALS control, -3.0; 95% CI, -4.0 to -1.9; P < .001; mean difference vs null control, -2.6; 95% CI, -3.6 to -1.5; P < .001). Clinical Performance Tool scores were significantly higher in the PediAppRREST group than control groups (mean difference vs PALS control, 1.4; 95% CI, 0.4 to 2.3; P = .002; mean difference vs null control, 1.1; 95% CI, 0.2 to 2.1; P = .01). The other secondary outcomes did not significantly differ among the study groups.
Conclusions And Relevance:
In this randomized clinical trial, the use of the PediAppRREST app resulted in fewer deviations from guidelines and a better team clinical performance during the management of pediatric cardiac arrest.
Trial Registration:
ClinicalTrials.gov Identifier: NCT04619498.
Related Concept Videos
Cardiopulmonary Resuscitation III: AED Use
Cardiopulmonary Resuscitation IV: Pharmacological Management
Drug Delivery: Enteral Route
Clinical Trials: Overview

